Clinical Trial

Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction

Name: Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction — clinical trial record (NCT07139912)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

A prospective ,multiple center Study about the Safety and Efficacy of the Thoracic Aortic Multi-Branch Stent Graft System, developed and manufactured by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., in patients with aortic arch pathologies.

Trial Details

NCT Number	NCT07139912
Lead Sponsor	Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Conditions	Aortic Arch Disease
Enrollment	96 participants
Start Date	2025-09
Primary Completion	2028-03 (estimated)
Study Completion	2032-03 (estimated)
Updated on ClinicalTrials.gov	2025-08-24